Table III.

Correlation between the average serum ADRA1A levels in the hysterocarcinoma group and clinicopathological characteristics.

Characteristics	No. of cases (n)	Low expression level of serum ADRA1A	High expression level of serum ADRA1A	P-value
Age (years)				0.158
<50	269	140	129
≥50	186	108	78
Lesion size (cm)				0.176
<4	231	98	133
≥4	224	150	74
Stage (FIGO)				0.019
I–II	276	178	98
III–IV	179	29	150
Differentiation degree				0.201
High	172	70	102
Middle and low	283	178	105
Myometrial invasion depth				0.191
<1/2	242	102	140
≥1/2	213	146	67
Pelvic lymph node metastasis				0.031
Yes	179	39	140
No	276	168	108
Tissue type				0.215
Squamous cell carcinoma	368	176	192
Non-squamous cell carcinoma	87	72	15

ADRA1A, adrenergic receptor α1.